Eosinophilic Fasciitis

A rare inflammatory thickening of the tissue beneath the skin

Quick Facts

  • Type: Rare autoimmune/inflammatory disorder
  • Main feature: Thick, tight, firm skin on arms and legs
  • Often follows: Strenuous exertion in some cases
  • Treatment: Corticosteroids and other immune medicines

Overview

Eosinophilic fasciitis, also called Shulman syndrome, is a rare condition in which the fascia, the band of connective tissue beneath the skin and around muscles, becomes inflamed and thickened. As the tissue tightens, the skin and underlying structures of the arms and legs feel firm, swollen, and bound down.

The name reflects the high number of a type of white blood cell called eosinophils often seen in the blood early in the disease. It can resemble scleroderma, but it differs in its pattern and usually spares the fingers and internal organs. With treatment, many people improve, though some are left with residual tightness.

Symptoms

Symptoms often begin over weeks and typically affect the limbs symmetrically:

  • Swelling of the arms and legs, sometimes after vigorous exercise
  • Progressive thickening and hardening of the skin and tissue underneath
  • A firm, tethered, or "orange-peel" appearance of the skin
  • Tightness that limits movement of joints such as the elbows, wrists, knees, and ankles
  • Aching, fatigue, and sometimes a groove along veins as surrounding tissue thickens

The hands and feet are usually less affected than in scleroderma, and the condition typically does not involve the internal organs.

Causes

The exact cause of eosinophilic fasciitis is not known. It is believed to involve an abnormal immune response that drives inflammation and scarring in the fascia. Possible triggers and associations that have been reported include:

  • Strenuous physical exertion shortly before symptoms begin
  • Certain infections in some people
  • An association with some blood and bone marrow disorders

It is not contagious, and in many cases no specific trigger is identified.

Risk Factors

  • Adulthood, with most cases in middle age
  • A history of intense physical exertion before onset in some people
  • Underlying blood or bone marrow conditions in a minority of cases

Because the disorder is rare, clear risk factors are limited, and most people have no obvious predisposing cause.

Diagnosis

Diagnosis can be challenging because the condition resembles other disorders. It is based on the clinical picture supported by tests:

  • Blood tests: Often show a raised eosinophil count and markers of inflammation, particularly early on.
  • MRI: Can show thickening and inflammation of the fascia and help guide where to biopsy.
  • Full-thickness biopsy: A deep skin-to-muscle biopsy showing inflamed, thickened fascia confirms the diagnosis.

Distinguishing it from scleroderma is important, as the pattern of skin involvement and lack of internal organ disease differ.

Treatment

Treatment aims to reduce inflammation, soften the tissue, and preserve joint movement.

  • Corticosteroids: Oral corticosteroids are the usual first-line treatment and often improve symptoms, especially when started early.
  • Other immune-modulating medicines: Additional medications may be added if the response is incomplete or to allow steroid doses to be lowered.
  • Physical therapy: Stretching and exercise help maintain range of motion and prevent lasting joint contractures.

Many people improve substantially with treatment. Some have residual tightness, and early treatment tends to give better outcomes.

Prevention

Because the cause is unknown, there is no proven way to prevent eosinophilic fasciitis. The most useful steps focus on limiting its impact:

  • Seek medical evaluation early for unexplained limb swelling and skin tightening
  • Begin and continue physical therapy to protect joint movement
  • Keep follow-up appointments to monitor the response to treatment

When to See a Doctor

See a doctor if you notice progressive swelling, firmness, or tightening of the skin on your arms or legs, especially if it is limiting how well your joints move. Early evaluation and treatment can improve the outcome and help prevent permanent stiffness.

Also seek care if skin changes are accompanied by significant fatigue, easy bruising, or other unexplained symptoms, which your doctor can assess.

Frequently Asked Questions

How is eosinophilic fasciitis different from scleroderma?

Both cause skin thickening, but eosinophilic fasciitis usually spares the fingers and internal organs and often follows exertion, with raised blood eosinophils early on. Scleroderma more commonly involves the fingers and internal organs. A deep biopsy helps tell them apart.

Is eosinophilic fasciitis curable?

Many people improve significantly with corticosteroids and other immune medicines, especially when treatment starts early. Some are left with residual tightness, and the condition can occasionally relapse, so follow-up is important.

What triggers it?

The cause is unknown. Some people report intense physical exertion before symptoms begin, and there are reported links with certain infections and blood disorders, but often no trigger is found.

Does it affect internal organs?

Typically no. Unlike scleroderma, eosinophilic fasciitis usually does not involve the internal organs, which is one feature that helps distinguish the two conditions.

Why is physical therapy important?

As the fascia thickens, joints can become stiff and develop contractures. Stretching and exercise help maintain range of motion and reduce the risk of permanent stiffness.

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with any questions about a medical condition.

References

  1. Genetic and Rare Diseases Information Center (GARD). Eosinophilic fasciitis.
  2. MedlinePlus, U.S. National Library of Medicine. Eosinophilic fasciitis.
  3. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
  4. National Organization for Rare Disorders (NORD). Eosinophilic Fasciitis.